GEN Exclusives

More »

GEN News Highlights

More »
Sep 18, 2007

GSK Awarded $41M DoD Contract to Further Antibacterial Research

  • GlaxoSmithKline inked a $41 million agreement from the Defense Threat Reduction Agency of the DoD. The funding, which will be provided over five years, will be used to identify and develop a class of antibacterials targeting gram-negative biothreats and conventional hospital pathogens.

    GSK says that it will also contribute to this effort by providing supplemental staff and covering other program costs. The research will focus on gram-negative pathogens such as Pseudomonas, Klebsiella, and Acinetobacter, which are increasingly resistant to all known classes of antibiotics.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Lab-Grown Vaginas

Which body part do you think will be successfully engineered in the lab next?